• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中α-突触核蛋白mRNA表达的改变。

Alteration in alpha-synuclein mRNA expression in Parkinson's disease.

作者信息

Kingsbury Ann E, Daniel Susan E, Sangha Hardev, Eisen Sarah, Lees Andrew J, Foster Oliver J F

机构信息

Queen Square Brain Bank for Neurological Disorders, Institute of Neurology, London, United Kingdom.

出版信息

Mov Disord. 2004 Feb;19(2):162-70. doi: 10.1002/mds.10683.

DOI:10.1002/mds.10683
PMID:14978671
Abstract

The presynaptic protein alpha-synuclein is considered to play an important role in the pathophysiology of Parkinson's disease (PD). Point mutations in the alpha-synuclein gene have been demonstrated in familial PD and alpha-synuclein is a major component of Lewy bodies, the pathological hallmark of the sporadic disease. It is not clear whether abnormal accumulation of alpha-synuclein is the result of abnormal levels of expression of the gene in neurodegenerative conditions. Expression of alpha-synuclein mRNA was therefore studied in control and PD brain using semiquantitative in situ hybridization. alpha-synuclein was expressed widely and hybridization signal was seen in most cortical regions, hippocampus, cerebellum, and brain stem. There was little mRNA in the striatum and no hybridization signal was detected in glia. High levels of alpha-synuclein mRNA expression in neurons did not seem to be a marker for Lewy body formation. Abundant signal was seen both in regions in which Lewy body deposition occurs commonly in idiopathic PD (PD), such as substantia nigra and frontal and temporal cortex, as well as in less susceptible regions, e.g. visual cortex. Quantitative comparison of mRNA expression in regions of predilection for Lewy body formation showed that mRNA expression was reduced significantly in melanized substantia nigra neurons and frontal cortex neurons in Parkinson's disease. In substantia nigra neurons there seemed to be a negative correlation between cellular mRNA expression and disease duration. These findings are in broad agreement with other studies of the expression of alpha-synuclein mRNA in human brain and suggest that Lewy body formation is unlikely to be the result of overexpression of alpha-synuclein.

摘要

突触前蛋白α-突触核蛋白被认为在帕金森病(PD)的病理生理学中起重要作用。α-突触核蛋白基因的点突变已在家族性PD中得到证实,并且α-突触核蛋白是路易小体的主要成分,而路易小体是散发性疾病的病理标志。目前尚不清楚α-突触核蛋白的异常积聚是否是神经退行性疾病中该基因表达水平异常的结果。因此,使用半定量原位杂交技术研究了对照脑和PD脑中α-突触核蛋白mRNA的表达。α-突触核蛋白广泛表达,在大多数皮质区域、海马、小脑和脑干中均可见杂交信号。纹状体中mRNA很少,在胶质细胞中未检测到杂交信号。神经元中高水平的α-突触核蛋白mRNA表达似乎不是路易小体形成的标志物。在特发性PD(PD)中通常发生路易小体沉积的区域,如黑质、额叶和颞叶皮质,以及在较不易受影响的区域,如视觉皮质,均可见丰富的信号。对路易小体形成倾向区域的mRNA表达进行定量比较表明,帕金森病中黑质黑素化神经元和额叶皮质神经元中的mRNA表达显著降低。在黑质神经元中,细胞mRNA表达与疾病持续时间之间似乎存在负相关。这些发现与其他关于人脑中α-突触核蛋白mRNA表达的研究大致一致,并表明路易小体的形成不太可能是α-突触核蛋白过度表达的结果。

相似文献

1
Alteration in alpha-synuclein mRNA expression in Parkinson's disease.帕金森病中α-突触核蛋白mRNA表达的改变。
Mov Disord. 2004 Feb;19(2):162-70. doi: 10.1002/mds.10683.
2
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.散发性帕金森病患者中α-突触核蛋白mRNA的水平。
Mov Disord. 2006 Oct;21(10):1703-8. doi: 10.1002/mds.21007.
3
Synphilin-1 is present in Lewy bodies in Parkinson's disease.α-突触核蛋白-1存在于帕金森病的路易小体中。
Ann Neurol. 2000 Apr;47(4):521-3.
4
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
5
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.大鼠黑质中α-突触核蛋白的过表达导致多巴胺能神经元丧失、α-突触核蛋白磷酸化及半胱天冬酶-9激活:类似于帕金森病的致病变化。
J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x.
6
Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.来自孔图尔西家族、帕金森病和阿尔茨海默病患者脑样本中的新型α-突触核蛋白免疫反应性蛋白。
Exp Neurol. 1998 Dec;154(2):684-90. doi: 10.1006/exnr.1998.6975.
7
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
8
[The mechanism of Lewy body formation in Parkinson's disease].[帕金森病中路易小体形成的机制]
Nihon Rinsho. 2000 Oct;58(10):2022-7.
9
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.帕金森病黑质致密部神经元中的神经丝信使核糖核酸减少。
J Comp Neurol. 1993 Mar 15;329(3):328-36. doi: 10.1002/cne.903290304.
10
Controversy: is Parkinson's disease a single disease entity? Yes.争议:帕金森病是单一的疾病实体吗?答案是肯定的。
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S31-7. doi: 10.1016/j.parkreldis.2005.02.011. Epub 2005 Apr 20.

引用本文的文献

1
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.需要一种个性化且全面的方法来抑制或补充帕金森病中的α-突触核蛋白(SNCA)。
NPJ Parkinsons Dis. 2025 Mar 4;11(1):42. doi: 10.1038/s41531-025-00887-3.
2
MicroRNA-Targeted Gene Regulation in Salivary Gland Tissue of De Novo Parkinson's Disease Patients.新发帕金森病患者唾液腺组织中微小RNA靶向的基因调控
Mol Neurobiol. 2025 Apr;62(4):4591-4604. doi: 10.1007/s12035-024-04581-y. Epub 2024 Oct 29.
3
Neuronal SNCA transcription during Lewy body formation.
路易小体形成过程中的神经元 SNCA 转录。
Acta Neuropathol Commun. 2023 Nov 23;11(1):185. doi: 10.1186/s40478-023-01687-7.
4
Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease.帕金森病的临床前研究现状与当代治疗策略
CNS Neurol Disord Drug Targets. 2024;23(8):996-1014. doi: 10.2174/0118715273258646230920074421.
5
State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson's and Alzheimer's Diseases: A Systematic Review and Meta-Analysis.作为帕金森病和阿尔茨海默病生物标志物及治疗靶点的微小RNA特征研究现状:一项系统综述与荟萃分析
Biomedicines. 2023 Apr 7;11(4):1113. doi: 10.3390/biomedicines11041113.
6
Modelling α-Synuclein Aggregation and Neurodegeneration with Fibril Seeds in Primary Cultures of Mouse Dopaminergic Neurons.用原纤维种子在原代培养的小鼠多巴胺能神经元中模拟 α-突触核蛋白聚集和神经退行性变。
Cells. 2022 May 13;11(10):1640. doi: 10.3390/cells11101640.
7
Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinic.激活胶质细胞源性神经营养因子/RET信号通路是成功治疗帕金森病的答案吗?从培养皿到临床的数据讨论。
Neural Regen Res. 2022 Jul;17(7):1462-1467. doi: 10.4103/1673-5374.327330.
8
Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease.柯萨奇病毒 B3 感染与帕金森病模型中α-突触核蛋白的相互作用。
PLoS Pathog. 2021 Oct 25;17(10):e1010018. doi: 10.1371/journal.ppat.1010018. eCollection 2021 Oct.
9
Activators of alpha synuclein expression identified by reporter cell line-based high throughput drug screen.基于报告细胞系高通量药物筛选鉴定的α-突触核蛋白表达激活剂。
Sci Rep. 2021 Oct 6;11(1):19857. doi: 10.1038/s41598-021-98841-9.
10
The Cerebellar Dopaminergic System.小脑多巴胺能系统
Front Syst Neurosci. 2021 Aug 5;15:650614. doi: 10.3389/fnsys.2021.650614. eCollection 2021.